These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23026688)

  • 21. Live viral vaccines in transplanted patients.
    L'Huillier AG; Posfay Barbe K
    Swiss Med Wkly; 2014; 144():w14005. PubMed ID: 25341637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal immunization against viral disease.
    Englund J; Glezen WP; Piedra PA
    Vaccine; 1998; 16(14-15):1456-63. PubMed ID: 9711788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes.
    Stobart CC; Moore ML
    Expert Rev Vaccines; 2015; 14(12):1563-72. PubMed ID: 26434947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potency control of modified live viral vaccines for veterinary use.
    Terpstra C; Kroese AH
    Vaccine; 1996 Jan; 14(1):13-8. PubMed ID: 8821643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep.
    van Rijn PA; Daus FJ; Maris-Veldhuis MA; Feenstra F; van Gennip RGP
    Vaccine; 2017 Jan; 35(2):231-237. PubMed ID: 27916409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploiting Mucosal Immunity for Antiviral Vaccines.
    Iwasaki A
    Annu Rev Immunol; 2016 May; 34():575-608. PubMed ID: 27168245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview and horizons in prevention of some human infectious diseases by vaccination.
    Sabin AB
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):114-27. PubMed ID: 210652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Better vaccinations - new approaches for targeted immunomodulation in healthy and immunosuppressed].
    Balmer ML; Berger CT
    Ther Umsch; 2014 Jan; 71(1):5-15. PubMed ID: 24394204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.
    Alexander-Miller MA
    J Immunol; 2014 Dec; 193(11):5363-9. PubMed ID: 25411431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
    Henry O; Brzostek J; Czajka H; Leviniene G; Reshetko O; Gasparini R; Pazdiora P; Plesca D; Desole MG; Kevalas R; Gabutti G; Povey M; Innis B
    Vaccine; 2018 Jan; 36(3):381-387. PubMed ID: 29224964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of age at the time of vaccination on antibody titers and feedlot performance in beef calves.
    Kirkpatrick JG; Step DL; Payton ME; Richards JB; McTague LF; Saliki JT; Confer AW; Cook BJ; Ingram SH; Wright JC
    J Am Vet Med Assoc; 2008 Jul; 233(1):136-42. PubMed ID: 18593324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.
    Coffin SE; Offit PA
    Adv Pediatr Infect Dis; 1997; 13():333-48. PubMed ID: 9544318
    [No Abstract]   [Full Text] [Related]  

  • 35. [What is the present status of the common virus vaccines?].
    Regnard J
    Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188
    [No Abstract]   [Full Text] [Related]  

  • 36. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
    Karron RA; Belshe RB; Wright PF; Thumar B; Burns B; Newman F; Cannon JC; Thompson J; Tsai T; Paschalis M; Wu SL; Mitcho Y; Hackell J; Murphy BR; Tatem JM
    Pediatr Infect Dis J; 2003 May; 22(5):394-405. PubMed ID: 12792378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of viral vaccines].
    Mertens T
    Immun Infekt; 1987 Nov; 15(6):197-202. PubMed ID: 3325407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modern methods for the development of antiviral vaccines].
    Raadsen MP; van Leeuwen LPM; van Gorp ECM; de Swart RL; Haagmans BL
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.